Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Mainz Biomed B.V. ( (MYNZ) ) is now available.
Mainz Biomed N.V. entered into an equity distribution agreement on October 1, 2025 with Maxim Group LLC to facilitate an at-the-market offering of up to $10 million in ordinary shares, supported by an effective shelf registration on Form F-3. On December 29, 2025, the company filed a prospectus supplement with the U.S. SEC allowing up to $2,152,823 in shares to be sold through Maxim under this program.
Between January 5 and January 23, 2026, Mainz Biomed sold 1,735,194 ordinary shares at prevailing Nasdaq Capital Market prices, raising gross proceeds of $2,152,822.40 before commissions and expenses and fully utilizing the prospectus supplement capacity. The remaining unused portion of the broader $10 million at-the-market facility remains available, giving the company additional flexibility to access capital in the future subject to market conditions.
The most recent analyst rating on (MYNZ) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Mainz Biomed B.V. stock, see the MYNZ Stock Forecast page.
Spark’s Take on MYNZ Stock
According to Spark, TipRanks’ AI Analyst, MYNZ is a Neutral.
The score is primarily constrained by weak financial performance, including persistent losses, negative operating cash flow, and high leverage. Technicals offer only modest support with short-term improvement but a longer-term downtrend. Valuation impact is neutral due to missing P/E and dividend yield data.
To see Spark’s full report on MYNZ stock, click here.
More about Mainz Biomed B.V.
Mainz Biomed N.V. is a Dutch public limited liability company operating in the biomedical sector, with its ordinary shares listed on the Nasdaq Capital Market. The company raises capital in the U.S. public markets through equity offerings, including at-the-market share issuance programs arranged with broker-dealers such as Maxim Group LLC.
Average Trading Volume: 592,215
Technical Sentiment Signal: Sell
Current Market Cap: $8.57M
Find detailed analytics on MYNZ stock on TipRanks’ Stock Analysis page.